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Abstract
Background: Human babesiosis is a rare tick-borne infectious disease. The clinical presentation ranges from an
asymptomatic form to a life threatening infection with severe hemolysis. Human babesiosis due to Babesia microti
is the most common and is endemic in North America.
Case presentation: We report a European patient with severe pancytopenia and reactive hemophagocytosis
related to a Babesia microti infection. Babesia infection was acquired during a travel in the USA.
Conclusion: Babesiosis should be considered in patients who traveled in endemic areas, especially North America
for the most common agent Babesia microti.
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Background
Human babesiosis is a tick-borne infectious disease
caused by intraerythrocytic protozoan species of the
genus Babesia transmitted by Ixodes. Babesia microti is
the most common cause of human babesiosis endemic
in USA on the northeastern seabord and the upper
midwest. The first confirmed case was a normosplenic
individual on Nantucket Island published in 1970 [1].
After additional cases the disease became known as
Nantucket fever. The incubation period may last from 1
to 9 weeks and clinical features are similar to those of
malaria. The severity is variable depending on the im-
mune status of the host, ranging from an asymptomatic
infection to a severe life threatening disease [2]. Severe
disease generally occurs in patients over the age of 50
years or with splenectomy, malignancy, HIV, or im-
munosuppressive medication. B. microti infections can
also rarely be acquired by transfusion of blood products
from asymptomatic donors [3]. In Europe few isolated
cases have been reported related to other Babesia species:
B. divergens and B. venatorum. Most of European cases
are observed in splenectomized patients [2].
Case report
A 82-year-old man living on the French Riviera
presented at the emergency department for fever and
chills lasting for 5 days. He complained of severe asthe-
nia. He came back two weeks ago from a travel in New
York city, USA with a two days stay on the Long Island
countryside. He did not note any insect bite during his
travel. Jaundice was noticed on examination as well as
slightly enlarged spleen and liver. Blood test showed an
abnormal blood cell count with neutropenia (0·5 G/L),
lymphopenia (0·3 G/L), thrombocytopenia (30×109/L)
and anemia (haemoglobin of 91 g/L) with a low reticulo-
cyte count (45 G/L). Blood test also showed increased C
reactive protein (154 mg/L), raised ferritin (5953 ng/ml)
and liver enzymes were elevated (ALT 56 UI/L (N<40),
AST 68 UI/L (N<53), Alkaline phosphatase 213 UI/L
(N<129), total bilirubin 48·9 μmol/L). Haptoglobin was
undetectable, LDH levels increased 620 UI/L (N<225)
and coagulation tests were in normal range. Routine
blood cultures were negative. Bone marrow aspiration
was performed because of the severe cytopenias
associated with a low reticulocyte count and showed
typical hemophagocytosis (Figure 1A). Microscopic
examination of the blood smear and the bone marrow
stained with Giemsa showed intra-eryhtrocytic parasites
(Figure 1B). The parasitemia was evaluated about 3% of
red blood cells. Rapid testing for Plasmodium falciparum
by PCR revealed negative. Intravenous treatment for
babesiosis with clindamycin and quinine was started.
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Patient’s clinical status improved with the resolution of
the fever after 3 days of treatment. Blood analysis
improved after the 10 days treatment course (haemoglo-
bin 104 g/L, platelets 220×109/L, neutrophils 3 G/L, C
reactive protein 16 mg/L). PCR testing on blood for
babesia was positive (Figure 2A). Babesia microti was
confirmed by PCR with specific primers (LDH gene
amplification) as shown on Figure 2B. Serology for
Borrelia burgdorferi, the agent of Lyme disease, was
negative.
Discussion
The clinical symptoms and the biological abnormalities
observed during babesiosis are very similar to Plasmo-
dium infection. Thus malaria is often evoked even in
travelers who have never visited a malarious area
because of the rare “airport malaria” [5]. This case
underline that the diagnosis of babesiosis should be
considered in patients who traveled in endemic areas,
especially North America, for the most common agent
Babesia microti. Babesia microti infection cannot be
ruled out in patients with intact spleen in contrary to
the European Babesia species (Babesia divergens and
Babesia venatorum) [2]. Moreover in some rare cases
spontaneous splenic rupture secondary to babesia
microti infection have been reported [6]. Babesiosis
has been reported to be associated to reactive
hemophagocytosis in few cases [7,8] however regenera-
tive hemolytic anemia is the most usual presentation [2].
In the present case the unusual severe neutropenia and
non-regenerative anemia led to the bone marrow aspir-
ation analysis. Typical hemophagocytosis was seen how-
ever without evidence of phagocytosis of babesia
infected red blood cells.
Diagnosis of babesia is usually strongly evoked by the
blood smear analysis and can be confirmed by specific
PCR, allowing to identify Babesia species and to exclude
plasmodium infection. Despite some similarities with
plasmodium, babesiosis does not respond to chloro-
quine. The use of clindamycin with quinine have been
shown to be effective as the combination of atovaquone
and azithromycin [2,9]. Because Borrelia burgdorferi, the
agent of Lyme disease, is transmitted by the same tick
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Figure 1 A; Bone marrow smear stained with Giemsa
(magnification x 100). The picture shows a macrophage with
phagocytosis of a neutrophil. On the right side an intra-erythrocytic
ring of Babesia microti can be observed in a red blood cell (arrow).
B; Blood smear stained with Giemsa (magnification x 100) showing intra-













Figure 2 Polymerase chain reaction results for Babesia microti in patients blood (C=H20, negative control; B.d= Babesia divergens
strain R87, positive control; B.m= Babesia microti strain T, positive control; P=Patient). PCR was done with specific primers for Babesia [4]
in 2A and specific amplification of the LDH gene of Babesia microti in 2B.
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and is endemic in North America it should systematic-
ally be screened by serology in these patients.
Conclusion
The diagnosis of babesiosis should be considered in
patients who traveled in endemic areas especially North
America for the most common agent Babesia microti.
Blood analyses usually show regenerative hemolytic anemia,
thrombocytopenia, and elevated liver enzymes. In case of
pancytopenia associated with non-regenerative anemia re-
active hemophagocytosis should be evoked. Diagnosis of
babesiosis can be made on blood smear analysis but needs
usually more specific tests, as PCR, to be confirmed.
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